Free Trial
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

Calithera Biosciences logo
$0.0002 0.00 (0.00%)
As of 11:47 AM Eastern

About Calithera Biosciences Stock (NASDAQ:CALA)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.05
Volume
474 shs
Average Volume
9,680 shs
Market Capitalization
$974.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Calithera Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

CALA MarketRank™: 

Calithera Biosciences scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Calithera Biosciences.

    • Percentage of Shares Shorted

      0.15% of the float of Calithera Biosciences has been sold short.
    • Short Interest Ratio / Days to Cover

      Calithera Biosciences has a short interest ratio ("days to cover") of 13.6, which indicates bearish sentiment.
    • Change versus previous month

    • Dividend Yield

      Calithera Biosciences does not currently pay a dividend.

    • Dividend Growth

      Calithera Biosciences does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      0.15% of the float of Calithera Biosciences has been sold short.
    • Short Interest Ratio / Days to Cover

      Calithera Biosciences has a short interest ratio ("days to cover") of 13.6, which indicates bearish sentiment.
    • Change versus previous month

    • MarketBeat Follows

      1 people have added Calithera Biosciences to their MarketBeat watchlist in the last 30 days.
    Receive CALA Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    CALA Stock News Headlines

    Calithera Biosciences Inc (CALA)
    Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
    Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
    Arcus Biosciences Inc (RCUS)
    Christina Cala
    CALA - Calithera Biosciences, Inc.
    See More Headlines

    CALA Stock Analysis - Frequently Asked Questions

    Calithera Biosciences' stock was trading at $0.0001 on January 1st, 2025. Since then, CALA stock has increased by 100.0% and is now trading at $0.0002.

    Calithera Biosciences, Inc. (NASDAQ:CALA) posted its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share for the quarter, topping analysts' consensus estimates of ($4.60) by $1.60. The biotechnology company earned $6.75 million during the quarter.

    Calithera Biosciences's stock reverse split on Wednesday, June 15th 2022.The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

    Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX) and First Solar (FSLR).

    Company Calendar

    Last Earnings
    11/08/2021
    Today
    8/28/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CALA
    CIK
    1496671
    Fax
    N/A
    Employees
    60
    Year Founded
    2010

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    N/A
    Price / Sales
    N/A
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    4,870,000
    Free Float
    4,550,000
    Market Cap
    $974.00
    Optionable
    Not Optionable
    Beta
    -2.77

    Social Links

    Analysts Agree—These Gold Picks Outshine the Rest Cover

    Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

    Get This Free Report

    This page (NASDAQ:CALA) was last updated on 8/28/2025 by MarketBeat.com Staff
    From Our Partners